Novartis' indacaterol beats GSK's salmeterol in COPD
Novartis says that Onbrez is better at improving lung function and reducing breathlessness than one of the current mainstays of treatment for chronic obstructive pulmonary disease. - News - PharmaTimes
by Rhonda Siddall
https://www.pharmatimes.com/news/novartis_indacaterol_beats_gsks_salmeterol_in_copd_982393